Literature DB >> 18278568

Lame ducks or fierce creatures? The role of oligodendrocytes in multiple sclerosis.

T Zeis1, N Schaeren-Wiemers.   

Abstract

In the pathogenesis of multiple sclerosis (MS), oligodendrocytes and its myelin sheaths are thought to be the primary target of destruction. The mechanism leading to oligodendrocyte injury and demyelination is still elusive. Oligodendrocytes are maintaining up to 50 internodes of myelin, which is an extraordinary metabolic demand. This makes them one of the most vulnerable cell types in the central nervous system (CNS), and even small insults can lead to oligodendrocyte impairment, demyelination, and axonal dysfunction. For this reason, oligodendrocytes are viewed as more or less the "lame ducks" of the CNS who can easily become victims. However, recent data demonstrate that this perception possibly needs to be revised. The latest data suggest that oligodendrocytes may also act as "fierce creatures," influencing the surrounding cells in many ways to preserve its own, as well as their function, allowing sustained functionality of the CNS upon an attack. In this review, the concept of "reactive or activated oligodendrocyte" is introduced, describing alterations in oligodendrocytes which are either protective mechanisms allowing survival in otherwise lethal environment or influence and possibly modulate the ongoing inflammation. Although "harnessed", oligodendrocytes might actively modulate and shape their environment and be part of the immune privilege of the brain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278568     DOI: 10.1007/s12031-008-9042-1

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  107 in total

1.  Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis.

Authors:  X Liu; D L Yao; H Webster
Journal:  Mult Scler       Date:  1995-04       Impact factor: 6.312

2.  Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.

Authors:  Melanie Greter; Frank L Heppner; Maria P Lemos; Bernhard M Odermatt; Norbert Goebels; Terri Laufer; Randolph J Noelle; Burkhard Becher
Journal:  Nat Med       Date:  2005-02-27       Impact factor: 53.440

3.  The IL-23/IL-17 axis in inflammation.

Authors:  Yoichiro Iwakura; Harumichi Ishigame
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

4.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

5.  Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor.

Authors:  Anna Jurewicz; Mariola Matysiak; Krzysztof Tybor; Lukasz Kilianek; Cedric S Raine; Krzysztof Selmaj
Journal:  Brain       Date:  2005-10-11       Impact factor: 13.501

6.  Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain.

Authors:  M Bergeron; J M Gidday; A Y Yu; G L Semenza; D M Ferriero; F R Sharp
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

7.  TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

Authors:  Mandy J McGeachy; Kristian S Bak-Jensen; Yi Chen; Cristina M Tato; Wendy Blumenschein; Terrill McClanahan; Daniel J Cua
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

8.  Glutamate receptor expression in multiple sclerosis lesions.

Authors:  Jia Newcombe; Alim Uddin; Rosamund Dove; Bela Patel; Lechoslaw Turski; Yukio Nishizawa; Terence Smith
Journal:  Brain Pathol       Date:  2007-10-09       Impact factor: 6.508

9.  Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system.

Authors:  P Villoslada; S L Hauser; I Bartke; J Unger; N Heald; D Rosenberg; S W Cheung; W C Mobley; S Fisher; C P Genain
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

Review 10.  Demyelination: the role of reactive oxygen and nitrogen species.

Authors:  K J Smith; R Kapoor; P A Felts
Journal:  Brain Pathol       Date:  1999-01       Impact factor: 6.508

View more
  8 in total

Review 1.  Neuroimmune pharmacology as a sub-discipline of medical neuroscience in the medical school curriculum.

Authors:  Robert W Freilich; Tsuneya Ikezu
Journal:  J Neuroimmune Pharmacol       Date:  2010-11-20       Impact factor: 4.147

2.  Quantitative temporal proteomic analysis of human embryonic stem cell differentiation into oligodendrocyte progenitor cells.

Authors:  Raghothama Chaerkady; Brian Letzen; Santosh Renuse; Nandini A Sahasrabuddhe; Praveen Kumar; Angelo H All; Nitish V Thakor; Bernard Delanghe; John D Gearhart; Akhilesh Pandey; Candace L Kerr
Journal:  Proteomics       Date:  2011-09-02       Impact factor: 3.984

3.  Defective adult oligodendrocyte and Schwann cell development, pigment pattern, and craniofacial morphology in puma mutant zebrafish having an alpha tubulin mutation.

Authors:  Tracy A Larson; Tiffany N Gordon; Hiu E Lau; David M Parichy
Journal:  Dev Biol       Date:  2010-08-05       Impact factor: 3.582

Review 4.  Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS.

Authors:  Daniel Chesik; Jacques De Keyser; Nadine Wilczak
Journal:  J Mol Neurosci       Date:  2008-02-26       Impact factor: 3.444

5.  Mature oligodendrocytes actively increase in vivo cytoskeletal plasticity following CNS damage.

Authors:  Giuseppe Locatelli; Arianna Baggiolini; Bettina Schreiner; Pushpalatha Palle; Ari Waisman; Burkhard Becher; Thorsten Buch
Journal:  J Neuroinflammation       Date:  2015-04-02       Impact factor: 8.322

6.  Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis.

Authors:  Ana Mendanha Falcão; David van Bruggen; Sueli Marques; Mandy Meijer; Sarah Jäkel; Eneritz Agirre; Elisa M Floriddia; Darya P Vanichkina; Charles Ffrench-Constant; Anna Williams; André Ortlieb Guerreiro-Cacais; Gonçalo Castelo-Branco
Journal:  Nat Med       Date:  2018-11-12       Impact factor: 53.440

7.  Autoimmune neuroinflammation triggers mitochondrial oxidation in oligodendrocytes.

Authors:  Jasmin Steudler; Timothy Ecott; Daniela C Ivan; Elisa Bouillet; Sabrina Walthert; Kristina Berve; Tobias P Dick; Britta Engelhardt; Giuseppe Locatelli
Journal:  Glia       Date:  2022-06-28       Impact factor: 8.073

8.  Subplate in a rat model of preterm hypoxia-ischemia.

Authors:  Chika Okusa; Franziska Oeschger; Vanessa Ginet; Wei-Zhi Wang; Anna Hoerder-Suabedissen; Tomohiro Matsuyama; Anita C Truttmann; Zoltán Molnár
Journal:  Ann Clin Transl Neurol       Date:  2014-09-30       Impact factor: 4.511

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.